Cite

HARVARD Citation

    Atisha‐Fregoso, Y. et al. (2021). Phase II Randomized Trial of Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis. Arthritis & rheumatology. 73 (1), pp. 121-131. [Online]. 
  
Back to record